Ductal carcinoma in situ and sentinel lymph node biopsy

Journal of Breast Cancer

Volumn 14, Issue 4, 2011, Pages 301-307

  Son, Bok Kyoung ^a   Bong, Jin Gu ^a   Park, Sung Hwan ^a   Jeong, Young Ju ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Breast; Ductal carcinoma in situ; Sentinel lymph node

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; ARTICLE; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PHYSICAL EXAMINATION; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE EVALUATION; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

EID: 84863072265     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.4.301     Document Type: Article

References (29)

1. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a fnal diagnosis of ductal carcinoma in situ. Am J Surg 2003;186:368-70.
2. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinva-sion? Ann Surg Oncol 2000;7:636-42.
3. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001;67:513-9.
4. Krag D, Weaver D, Ashikaga T, Mofat F, Klimberg VS, Shriver C, et al. Te sentinel node in breast cancer--a multicenter validation study. N Engl JMed 1998;339:941-6.
5. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
6. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000; 7:15-20.
7. Wilkie C, White L, Dupont E, Cantor A, Cox CE. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005;190:563-6.
8. Tada K, Ogiya A, Kimura K, Morizono H, Iijima K, Myagi Y, et al. Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer. World J Surg Oncol 2010;8:6.
9. Intra M, Rotmensz N, Veronesi P Colleoni M, Iodice S, Paganelli G, et al. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 2008;247:315-9.
10. Zavagno G, Carcoforo P Marconato R, Franchini Z, Scalco G, Burelli P et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 2005;5:28.
11. Intra M, Veronesi P Mazzarol G, Galimberti V, Luini A, Sacchini V, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309-13.
12. Cody HS 3rd, Van Zee KJ. Point: sentinel lymph node biopsy is indicated for patients with DCIS. J Natl Compr Canc Netw 2003; 1:199-206.
13. Yen TW, Hunt KK, Ross MI, Mrza NQ, Babiera GV, Meric-Bernstam F, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-26.
14. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 2005;62:253-7.
15. Ciatto S, Houssami N, Ambrogetti D, Bianchi S, Bonardi R, Brancato B, et al. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat 2007;101:291-7.
16. Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specifc estimates. Cancer 2007;109:487-95.
17. Crowe JP Jr, Rim A, Patrick RJ, Rybicki LA, Grundfest-Broniatowski SF, Kim JA, et al. Does core needle breast biopsy accurately refect breast pathology? Surgery 2003;134:523-6.
18. Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 2006;98: 311-4.
19. Kim T Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006;106:4-16.
20. Son GS, Kim TH, Um JW, Lee JB, Bae JW, Koo BH. Axillary lymph node metastasis in patients of ductal carcinoma in situ or ductal carcinoma in situ with microinvasion. J Korean Breast Cancer Soc 2004;7:180-4.
21. Doyle B, Al-Mudhaffer M, Kennedy MM, O'Doherty A, Flanagan F, McDermott EW, et al. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justifed? J Clin Pathol 2009;62:534-8.
22. Dillon MF, McDermott EW, Quinn CM, O'Doherty A, O'Higgins N, Hill AD. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 2006;93:559-63.
23. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 2008; 196:81-7.
24. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Der-shaw DD. The breast imaging reporting and data system: positive predictive value of mammographic features and fnal assessment categories. AJR Am J Roentgenol 1998;171:35-40.
25. Bagnall MJ, Evans AJ, Wilson AR, Pinder SE, Denley H, Geraghty JG, et al. Predicting invasion in mammographically detected microcalcifcation. Clin Radiol 2001;56:828-32.
26. Leikola J, Heikkilä P Pamilo M, Salmenkivi K, Von Smitten K, Leide-nius M. Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy. Acta Oncol 2007;46:798-802.
27. Lee CH, Carter D, Philpotts LE, Couce ME, Horvath LJ, Lange RC, et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 2000;217:466-70.
28. Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 2011;260:119-28.
29. Shah VI, Raju U, Chitale D, Deshpande V, Gregory N, Strand V. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic fndings in 27 concecutive cases of missed breast cancer. Cancer 2003;97:1824-31.